Factor Bioscience Profile

January 22, 2021

Brief version of a profile of a Cambridge, MA, company doing research and manufacture of MRNA technology that will slow and even reverse the aging process in human beings.

Read More

More News

Factor Bioscience and Eterna Therapeutics Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases

October 17, 2024

Factor Bioscience to Deliver Six Presentations at the International Society for Stem Cell Research (ISSCR) 2024 Annual Meeting

July 9, 2024

Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods for Therapeutic Gene Editing

May 28, 2024

Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

April 23, 2024

Factor Bioscience Expands Translational Science Team, Appoints Kyle Garland, Ph.D., as Director of Translational Science

April 9, 2024